Researchers from the Ann Arbor-based University of Michigan analyzed Medicare Provider Analysis and Review files collected between 2015 and 2018. They focused on “beneficiary index admission for a procedure as well as any subsequent hospitalization,” and compared the data with information on hospital characteristics culled from the Annual Survey of the American Hospital Association.
Across 10 high-risk procedures — including bariatric surgery, open aortic aneurysm, esophagectomy and hip and knee replacements — there was no consistent difference in monthlong mortality rates when comparing hospitals located in communities with a high level of competition versus a lower level of competition from other hospitals.
Thirty-day readmission trends also showed that competition does not play a measurable factor in surgical outcomes for five of the procedures studies. In fact, three of the surgeries — bariatric surgery, esophagectomy and pancreatectomy — showed no difference in outcomes.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
